Search Results for: Molecular Templates Announces Dosing of
Articles
October 30, 2017
Molecular Templates Announces Dosing of First Patient in Phase 1 Expansion Study October 30, 2017
Molecular Templates, Inc. recently announced the dosing of the first patient in a Phase 1 expansion study of MT-3724, a...
January 21, 2021
Molecular Templates Announces FDA Acceptance of IND Application for a PD-L1-Targeted Engineered Toxin Body Enabled With Proprietary Antigen Seeding Technology January 21, 2021
Molecular Templates, Inc. recently announced the US FDA has accepted its Investigational New Drug (IND) application for MT-6402, a next-generation ETB targeting PD-L1 that is enabled with….
